Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Share-based Compensation: 2017-2024

Historic Share-based Compensation for IDEAYA Biosciences (IDYA) over the last 8 years, with Dec 2024 value amounting to $34.7 million.

  • IDEAYA Biosciences' Share-based Compensation rose 32.58% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.8 million, marking a year-over-year increase of 45.74%. This contributed to the annual value of $34.7 million for FY2024, which is 87.93% up from last year.
  • Latest data reveals that IDEAYA Biosciences reported Share-based Compensation of $34.7 million as of FY2024, which was up 87.93% from $18.5 million recorded in FY2023.
  • IDEAYA Biosciences' Share-based Compensation's 5-year high stood at $34.7 million during FY2024, with a 5-year trough of $3.6 million in FY2020.
  • Moreover, its 3-year median value for Share-based Compensation was $18.5 million (2023), whereas its average is $21.6 million.
  • Data for IDEAYA Biosciences' Share-based Compensation shows a peak YoY soared of 128.23% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows IDEAYA Biosciences' Share-based Compensation stood at $3.6 million in 2020, then soared by 128.23% to $8.2 million in 2021, then surged by 41.18% to $11.6 million in 2022, then spiked by 58.99% to $18.5 million in 2023, then soared by 87.93% to $34.7 million in 2024.